Nisa Investment Advisors
APLT

Nisa Investment Advisors’s Applied Therapeutics APLT Stock Holding History

Nisa Investment Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-573
Closed -$178 – 2989
2025
Q2 		$178 Sell
573
-274
-32% -$106 ﹤0.01% 3009
2025
Q1 		$414 Sell
847
-1,753
-67% -$1.03K ﹤0.01% 2835
2024
Q4 		$2.23K Buy
2,600
+2,298
+761% +$14.4K ﹤0.01% 2453
2024
Q3 		$2.57K Buy
+302
New +$1.78K ﹤0.01% 2347
2021
Q3 		– Sell
-2,000
Closed -$42 – 2304
2021
Q2 		$42 Buy
+2,000
New +$37.9K ﹤0.01% 1985
2020
Q4 		– Sell
-300
Closed -$6K – 2296
2020
Q3 		$6K Buy
+300
New +$7.8K ﹤0.01% 2173

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Nisa Investment Advisors's APLT Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Applied Therapeutics (APLT) in Q3 2025, closing a stake of 573 shares — an estimated $178 sold.

Nisa Investment Advisors first reported a position in APLT in Q3 2020 and held it in 6 quarters. The position peaked at $6K in Q3 2020. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Applied Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 573 Applied Therapeutics shares in Q3 2025, an estimated $178.
  • Nisa Investment Advisors first reported a position in Applied Therapeutics in Q3 2020 and held it in 6 quarters.
  • Nisa Investment Advisors's Applied Therapeutics position peaked at $6K in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.